Epitope-specific airway-resident CD4+ T cell dynamics during experimental human RSV infection
Open Access
- 9 December 2019
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 130 (1), 523-538
- https://doi.org/10.1172/jci131696
Abstract
BACKGROUND. Respiratory syncytial virus (RSV) is an important cause of acute pulmonary disease and one of the last remaining major infections of childhood for which there is no vaccine. CD4+ T cells play a key role in antiviral immunity, but they have been little studied in the human lung. METHODS. Healthy adult volunteers were inoculated i.n. with RSV A Memphis 37. CD4+ T cells in blood and the lower airway were analyzed by flow cytometry and immunohistochemistry. Bronchial soluble mediators were measured using quantitative PCR and MesoScale Discovery. Epitope mapping was performed by IFN-γ ELISpot screening, confirmed by in vitro MHC binding. RESULTS. Activated CD4+ T cell frequencies in bronchoalveolar lavage correlated strongly with local C-X-C motif chemokine 10 levels. Thirty-nine epitopes were identified, predominantly toward the 3′ end of the viral genome. Five novel MHC II tetramers were made using an immunodominant EFYQSTCSAVSKGYL (F-EFY) epitope restricted to HLA-DR4, -DR9, and -DR11 (combined allelic frequency: 15% in Europeans) and G-DDF restricted to HLA-DPA1*01:03/DPB1*02:01 and -DPA1*01:03/DPB1*04:01 (allelic frequency: 55%). Tetramer labeling revealed enrichment of resident memory CD4+ T (Trm) cells in the lower airway; these Trm cells displayed progressive differentiation, downregulation of costimulatory molecules, and elevated CXCR3 expression as infection evolved. CONCLUSIONS. Human infection challenge provides a unique opportunity to study the breadth of specificity and dynamics of RSV-specific T-cell responses in the target organ, allowing the precise investigation of Trm recognizing novel viral antigens over time. The new tools that we describe enable precise tracking of RSV-specific CD4+ cells, potentially accelerating the development of effective vaccines. TRIAL REGISTRATION. ClinicalTrials.gov NCT02755948. FUNDING. Medical Research Council, Wellcome Trust, National Institute for Health Research.Keywords
Funding Information
- Medical Research Council (G0902266)
- Wellcome Trust (08,805/Z/08/Z)
This publication has 68 references indexed in Scilit:
- Sensing and alarm function of resident memory CD8+ T cellsNature Immunology, 2013
- Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infectionMucosal Immunology, 2012
- Induction of CXCR3- and CCR5-associated chemokines during acute hepatitis C virus infectionJournal of Hepatology, 2011
- Follicular Helper CD4 T Cells (TFH)Annual Review of Immunology, 2011
- Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypesImmunogenetics, 2011
- High prevalence of low affinity peptide–MHC II tetramer–negative effectors during polyclonal CD4+ T cell responsesThe Journal of Experimental Medicine, 2011
- Infection of HLA-DR1 Transgenic Mice with a Human Isolate of Influenza A Virus (H1N1) Primes a Diverse CD4 T-Cell Repertoire That Includes CD4 T Cells with Heterosubtypic Cross-Reactivity to Avian (H5N1) Influenza VirusJournal of Virology, 2009
- Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cellsProceedings of the National Academy of Sciences of the United States of America, 2008
- CXCL10/CXCR3‐mediated responses promote immunity to respiratory syncytial virus infection by augmenting dendritic cell and CD8+ T cell efficacyEuropean Journal of Immunology, 2008
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973